Streetbeat News

Analyst Ratings

MRNA

Moderna shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $125 to $90.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:28 pm

PLYM

Wedbush analyst Henry Coffey maintains a Neutral rating on Plymouth Industrial REIT (NYSE:PLYM) and raises the price target from $23 to $25.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:27 pm

STAG

Wedbush analyst Richard Anderson maintains an Outperform rating on Stag Industrial (NYSE:STAG) and raises the price target from $44 to $45.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:25 pm

BXP

Wedbush analyst Richard Anderson maintains a Neutral rating on BXP (NYSE:BXP) and raises the price target from $63 to $70.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:24 pm

CDP

Wedbush analyst Richard Anderson maintains an Outperform rating on COPT Defense (NYSE:CDP) and raises the price target from $28 to $33.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:23 pm

MAA

Wedbush analyst Richard Anderson maintains an Outperform rating on Mid-America Apartment (NYSE:MAA) and raises the price target from $154 to $184.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:21 pm

LLY

Guggenheim analyst Seamus Fernandez maintains a Buy rating on Eli Lilly (NYSE:LLY) and raises the price target from $855 to $884.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:17 pm

JNJ

Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Johnson & Johnson (NYSE:JNJ) and maintains a $215 price target.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:07 pm

ABBV

Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on AbbVie (NYSE:ABBV) and maintains a $200 price target.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:05 pm

TIXT

TELUS International shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform. Multiple firms also lowered their price targets following weak Q2 financial results and soft FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 6:05 pm